Research and Project

  • Wallis CY Lau. UCL School of Pharmacy, UK. OHDSI Comparative effectiveness and safety of direct ORal Anticoagulants in patients with atrial fibrilation: a standardiZed Observational data Network study (CORAZON)
  • Schilling. Prescribing Patterns of Systemic Immunomodulating Agents of Atopic Dermatitis
  • NA. University of Hong Kong, Hing Kong; UCL School of Pharmacy, United Kingdom. Covid-19 pandEmic impacts on mental health Related conditions Via multi-database nEtwork: a Longitudinal Observational study (CERVELLO)
  • Jenna Reps. Janssen Research and Development, Titusville, NJ, USA. Evaluating the Sensitivity Of Prediction Model Development and Performance Due To Phenotypes Applied To COVID-19 VACCINES
  • Thamir M Alshammari. College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia. EUMAEAUS: Evaluating Use of Methods for Adverse Event Under Surveilance (for vaccines)
  • Jeniffer Lane. NDORMS, University of Oxford. MSKAI – Musculoskeletal adverse events following hormonal treatment for breast cancer
  • Aki Nishimura. University of California – Los Angeles. Association of alpha-1 blocker (alpha-1B) on coronavirus disease (COVID-19) susceptability and severity
  • Anna Ostropolets. OHDSI. Sensitivity analysis of design choices for monitoring adverse events of special interest in vaccine safety for BEST
  • Seng Chan You. Ajou University, Korea. OHDSI: Comparative risk of the incident between histamine-2 receptor antagonists
  • Deniel Prieto – Alhambra Patrick Ryan. University of Oxford, Oxford, UK, Depertment of Biomedical Informatics, Columbia University. Project Sc(y)lla Characterization: SARS-Cov-2 Large-scale Longitudinal Analyses on the comparative safety and effectiveness of treatments under evaluation for COVID-19 across an international observational data network

%d bloggers like this: